View Older Stories
-
HealthEquity (HQY) Tops Q3 EPS by 10c, Beats on Revenue; Offers Guidance
-
HealthEquity partners with Parloa to deploy agentic AI customer support
-
HealthEquity launches GLP-1 telehealth and direct HSA enrollment platforms
-
HealthEquity appoints new marketing chief and sales leader
-
HealthEquity, Inc (HQY) PT Raised at RBC Capital as 'Momentum Continues'
-
HealthEquity (HQY) Tops Q2 EPS by 16c, provides guidance
-
HealthEquity, Inc (HQY) PT Lowered to $109 at RBC Capital
-
HealthEquity, Inc (HQY) PT Raised to $120 at Raymond James
-
Mizuho Reiterates Outperform Rating on HealthEquity, Inc (HQY)
-
HealthEquity (HQY) call put ratio 1 call to 1.6 puts with a focus on June 85 puts as share price up 9.8%
-
KeyBanc Reiterates Overweight on HealthEquity (HQY) Following F1Q Beat & FY Raise
-
BTIG Reiterates Buy Rating on HealthEquity, Inc (HQY)
-
Goldman Sachs Reiterates Neutral Rating on HealthEquity, Inc (HQY)
-
HealthEquity, Inc (HQY) PT Raised to $117 at Citizens JMP
-
HealthEquity (HQY) Tops Q1 EPS by 15c, provides guidance
-
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, A LEADING LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, TRUSTED AND LEADING INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, A TOP RANKED LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
TOP RANKED ROSEN LAW FIRM Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, A LEADING LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, A LONGSTANDING FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, A TOP RANKED LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
-
Raymond James Upgrades HealthEquity, Inc (HQY) to Strong Buy
-
KeyBanc on HealthEquity, Inc (HQY): 'Buying Opportunity Emerges'; PT Lowered
-
BTIG Reiterates Buy Rating on HealthEquity, Inc (HQY)
-
HealthEquity, Inc (HQY) PT Lowered to $110 at Citizens JMP
-
After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more
-
HealthEquity (HQY) Misses Q4 EPS by 3c, provides guidance
-
HealthEquity (HQY) Reports Year-End Sales Metrics
-
HealthEquity, Inc (HQY) PT Raised to $120 at JMP Securities
-
HealthEquity (HQY) Announces Record Year-End HSA Sales Outlook
-
HealthEquity, Inc (HQY) PT Raised to $105 at RBC Capital Following F3Q Beat-and-Raise
-
HealthEquity (HQY) Tops Q3 EPS by 6c, provides guidance
-
Mizuho Starts HealthEquity, Inc (HQY) at Outperform
-
Goldman Sachs Starts HealthEquity, Inc (HQY) at Neutral
-
HealthEquity (HQY) Announces CEO Retirement
-
RBC makes changes to its Top 30 Global Ideas for 2024
-
HealthEquity, Inc (HQY) PT Raised to $100 at RBC Capital
-
KeyBanc Reiterates Overweight Rating on HealthEquity, Inc (HQY)
-
HealthEquity (HQY) Files Mixed Shelf
-
HealthEquity (HQY) 1300 contracts of September 85 calls amid wide intraday share price movement
-
KeyBanc Reiterates Overweight Rating on HealthEquity, Inc (HQY)

